Latest IR information
IR News
- 2026.05.12
- CRADA with NIAID on BCV for Post-Transplant Lymphoproliferative Disorder (PTLD) Extended for Three Years — SymBio to Advance Development of Brincidofovir (BCV) for EBV-Associated Diseases —
- 2026.05.07
- Summary of Consolidated Financial Statements for the Three Months ended March 31, 2026 [Japanese GAAP]
- 2026.05.01
- Notice Regarding the Monthly Exercise Status of the 58th and 66th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued through Third-Party Allotment
- 2026.04.22
- Brincidofovir Shows Efficacy in Preclinical Study of EBV-Associated Gastric Carcinoma Poster Presentation Accepted at the ASCO Annual Meeting 2026
- 2026.04.21
- Notice Regarding Notice of the Large Volume Exercise of the 66th Stock Acquisition Rights (with Exercise Price Revision Clauses) Issued by way of Third-Party Allotment